Nitazoxanide: Difference between revisions
From IDWiki
(Created page with "* Indications: {{#ask: Is treated by::nitazoxanide }}") |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
* Indications: {{#ask: [[Is treated by::nitazoxanide]] }} |
* Indications: {{#ask: [[Is treated by::nitazoxanide]] }} |
||
| + | * Usual dose: 500 mg p.o. twice daily |
||
| + | * Not approved in Canada, needs SAP |
||
| + | [[Category:Antiparasitics]] |
||
Latest revision as of 10:18, 21 July 2023
- Indications: Blastocystis hominis, Cryptosporidium hominis, Cystoisospora belli, Giardia lamblia
- Usual dose: 500 mg p.o. twice daily
- Not approved in Canada, needs SAP
